Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Lynde

Showing results (41-50 of 141) with videos related to

Pageof 15
Sort By:
American Journal of Clinical Dermatology|March 18, 2018
Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual ComparisonBrigitte Dréno, Robert Bissonnette, Angélique Gagné-Henley, et al.
Journal of Drugs in Dermatology : JDD|August 2, 2024
INDIVIDUAL ARTICLE: NECOM 4: Algorithm Integrating Skincare for the Management of Immunotherapy-Related Cutaneous Adverse Events for Cancer Patients and SurvivorsAda Girnita, Cynthia Fournier, Peter Bjerring, et al.
Journal of Cutaneous Medicine and Surgery|May 16, 2013
Understanding and assessing potential serious adverse events: a practical approach to understanding the benefits and harm of psoriasis treatmentsKim Papp, Lyn Guenther, Neil Shear, et al.
Journal of the American Academy of Dermatology|September 18, 2017
Use of capsule endoscopy to identify lesions suggestive of Crohn's disease in patients with moderate to severe psoriasisRobert Bissonnette, Raja Tamaz, Chantal Bolduc, et al.
Journal of the American Academy of Dermatology|January 9, 2007
Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgarisZoe D Draelos, Eric Carter, J Michael Maloney, et al.
Cutis|February 27, 2010
Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasisYves Poulin, Kim Papp, Robert Bissonnette, et al.
Journal of Drugs in Dermatology : JDD|December 13, 2021
SUPPLEMENT INDIVIDUAL ARTICLE: Skincare for Cancer Patients in ScandinaviaAda Girnita, Henrik Lorentzen, Sampsa Kauppi, et al.
American Journal of Clinical Dermatology|June 19, 2019
Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial AcneBrigitte Dréno, Robert Bissonnette, Angélique Gagné-Henley, et al.
Journal of Drugs in Dermatology : JDD|May 6, 2025
INDIVIDUAL ARTICLE: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer TherapyAda Girnita, Peter Bjerring, Gabriela Llado Grove, et al.
Journal of Drugs in Dermatology : JDD|November 11, 2010
Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safetyLawrence E Eichenfield, Joseph L Jorizzo, Thomas Dirschka, et al.
Pageof 15

Showing results (41-50 of 141) with videos related to

Sort By:
Pageof 15
American Journal of Clinical Dermatology|March 18, 2018
Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual ComparisonBrigitte Dréno, Robert Bissonnette, Angélique Gagné-Henley, et al.
Journal of Drugs in Dermatology : JDD|August 2, 2024
INDIVIDUAL ARTICLE: NECOM 4: Algorithm Integrating Skincare for the Management of Immunotherapy-Related Cutaneous Adverse Events for Cancer Patients and SurvivorsAda Girnita, Cynthia Fournier, Peter Bjerring, et al.
Journal of Cutaneous Medicine and Surgery|May 16, 2013
Understanding and assessing potential serious adverse events: a practical approach to understanding the benefits and harm of psoriasis treatmentsKim Papp, Lyn Guenther, Neil Shear, et al.
Journal of the American Academy of Dermatology|September 18, 2017
Use of capsule endoscopy to identify lesions suggestive of Crohn's disease in patients with moderate to severe psoriasisRobert Bissonnette, Raja Tamaz, Chantal Bolduc, et al.
Journal of the American Academy of Dermatology|January 9, 2007
Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgarisZoe D Draelos, Eric Carter, J Michael Maloney, et al.
Cutis|February 27, 2010
Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasisYves Poulin, Kim Papp, Robert Bissonnette, et al.
Journal of Drugs in Dermatology : JDD|December 13, 2021
SUPPLEMENT INDIVIDUAL ARTICLE: Skincare for Cancer Patients in ScandinaviaAda Girnita, Henrik Lorentzen, Sampsa Kauppi, et al.
American Journal of Clinical Dermatology|June 19, 2019
Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial AcneBrigitte Dréno, Robert Bissonnette, Angélique Gagné-Henley, et al.
Journal of Drugs in Dermatology : JDD|May 6, 2025
INDIVIDUAL ARTICLE: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer TherapyAda Girnita, Peter Bjerring, Gabriela Llado Grove, et al.
Journal of Drugs in Dermatology : JDD|November 11, 2010
Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safetyLawrence E Eichenfield, Joseph L Jorizzo, Thomas Dirschka, et al.
Pageof 15